These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36012949)

  • 1. Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors.
    Muraro E; Vinante L; Fratta E; Bearz A; Höfler D; Steffan A; Baboci L
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy.
    Basar OY; Mohammed S; Qoronfleh MW; Acar A
    Front Cell Dev Biol; 2024; 12():1369597. PubMed ID: 38813084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer.
    Ilari A; Cogliati V; Sherif N; Grassilli E; Ramazzotti D; Cordani N; Cazzaniga G; Di Bella C; Lavitrano M; Cazzaniga ME; Cerrito MG
    Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: An exceptional responder of low-dose continuous 5-FU in a patient with
    Chan B; Lee JS; Yuan Y
    Front Oncol; 2023; 13():1305584. PubMed ID: 38288100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer.
    Alvarado-Miranda A; Lara-Medina FU; Muñoz-Montaño WR; Zinser-Sierra JW; Galeana PAC; Garza CV; Sanchez Benitez D; Limón Rodríguez JA; Arce Salinas CH; Guijosa A; Arrieta O
    Curr Oncol; 2023 Jun; 30(7):6097-6110. PubMed ID: 37504314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer.
    Chai Y; Liu J; Jiang M; He M; Wang Z; Ma F; Wang J; Yuan P; Luo Y; Xu B; Li Q
    Thorac Cancer; 2023 Aug; 14(23):2259-2268. PubMed ID: 37402471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Breast Cancer: An Overlook on Current Strategies.
    Iacopetta D; Ceramella J; Baldino N; Sinicropi MS; Catalano A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic Chemotherapy.
    Cazzaniga ME; Cordani N; Capici S; Cogliati V; Riva F; Cerrito MG
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
    Kerbel RS; Shaked Y
    Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows.
    Cazzaniga ME; Capici S; Cordani N; Cogliati V; Pepe FF; Riva F; Cerrito MG
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project.
    Cazzaniga ME; Munzone E; Bocci G; Afonso N; Gomez P; Langkjer S; Petru E; Pivot X; Sánchez Rovira P; Wysocki P; Torri V
    Adv Ther; 2019 Feb; 36(2):381-406. PubMed ID: 30565179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients.
    Trevisan B; Pepe FF; Vallini I; Montagna E; Amoroso D; Berardi R; Butera A; Cagossi K; Cavanna L; Ciccarese M; Cinieri S; Cretella E; De Conciliis E; Febbraro A; Ferraù F; Ferzi A; Baldelli A; Fontana A; Gambaro AR; Garrone O; Gebbia V; Generali D; Gianni L; Giovanardi F; Grassadonia A; Leonardi V; Sarti S; Musolino A; Nicolini M; Putzu C; Riccardi F; Santini D; Sarobba MG; Schintu MG; Scognamiglio G; Spadaro P; Taverniti C; Toniolo D; Tralongo P; Turletti A; Valenza R; Valerio MR; Vici P; Clivio L; Torri V; Cazzaniga ME;
    Sci Rep; 2023 Jul; 13(1):12255. PubMed ID: 37507480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration
    Scagliotti A; Capizzi L; Cazzaniga ME; Ilari A; De Giorgi M; Cordani N; Gallazzi M; Bruno A; Pelosi G; Albini A; Lavitrano M; Grassilli E; Cerrito MG
    Front Oncol; 2022; 12():998274. PubMed ID: 36531071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.
    Cazzaniga ME; Vallini I; Montagna E; Amoroso D; Berardi R; Butera A; Cagossi K; Cavanna L; Ciccarese M; Cinieri S; Cretella E; De Conciliis E; Febbraro A; Ferraù F; Ferzi A; Baldelli A; Fontana A; Gambaro AR; Garrone O; Gebbia V; Generali D; Gianni L; Giovanardi F; Grassadonia A; Leonardi V; Marchetti P; Sarti S; Musolino A; Nicolini M; Putzu C; Riccardi F; Santini D; Saracchini S; Sarobba MG; Schintu MG; Scognamiglio G; Spadaro P; Taverniti C; Toniolo D; Tralongo P; Turletti A; Valenza R; Valerio MR; Vici P; Di Mauro P; Cogliati V; Capici S; Clivio L; Torri V;
    Breast Cancer Res Treat; 2021 Dec; 190(3):415-424. PubMed ID: 34546500
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.